Skip to main content
. 2024 Jun 21;42(9):929–953. doi: 10.1007/s40273-024-01388-6

Fig. 2.

Fig. 2

Summary of the cost-effectiveness results of the included studies comparing to self-monitoring of blood glucose levels using finger pricks or other CGM devices. Note: Some of the studies reported multiple ICERs. The results for three studies [7, 28, 30] are not included because of missing incremental costs and/or QALY data. CGM continuous glucose monitoring, ICERs incremental cost-effectiveness ratios, QALYs quality-adjusted life-years, SMBG self-monitoring of blood glucose, WTP willingness to pay